Dickey H, Watson V, Zangelidis A. Is it all about money? An examination of the motives behind moonlighting. Appl Econ. 2010 Nov 3;43(26):3767-74. doi: 10.1080/00036841003724403
Mansfield CA, Finkelstein EA, Wood DW, Rowe BR. How willing are U.S. citizens to accept the costs of counterterrorism policies? Presented at the Institute for Homeland Security Solutions Research Symposium; November 2010. Research Triangle Park, NC.
Pattanayak SK, Poulos C, Yang JC, Patil S. How valuable are environmental health interventions? Evaluation of water and sanitation programmes in India. Bull World Health Organ. 2010 Jul 1;88(7):535-42.
Poulos C, Yang J, Patil SR, Pattanayak SK, Wood S, Goodyear L. Consumer preferences for household water treatment products in Andhra Pradesh, India: an application of choice-format conjoint analysis. Poster presented at the 3rd Biennial Conference of the American Society of Health Economists; June 2010.
Myers KH, Parsons GR, Edwards PET. Measuring the recreational use value of migratory shorebirds on the Delaware Bay. Marine Resource Economics. 2010 Apr 23;25(3):247-64.
Van Houtven G, Mansfield CA. Nonuse valuation survey for Klamath River Basin restoration. Presented at the Nonuse valuation survey for Klamath River Basin restoration; April 2010. Tempe, AZ.
Smith VK, Evans MF, Banzhaf HS, Poulos C. Can weak substitution be rehabilitated? Environ Resour Econ (Dordr). 2010 Feb 1;45(2):203-21.
Brown DS, Johnson FR, Poulos C, Messonnier ML. Mothers' preferences and willingness to pay for vaccinating daughters against human papillomavirus. Vaccine. 2010 Feb 1;28(7):1702-8.
Mansfield CA, Van Houtven GL, von Haefen R, Phaneuf DJ. Measuring nutrient reduction benefits for policy analysis using linked non-market valuation and environmental assessment models. Presented at the W2133 Annual Meetings; February 2010. Tucson, AZ.
Jeuland M, Maskery B, Cook J, Poulos C, Clemens J, Lauria D, Stewart J, Lucas M, Whittington D. Incorporating cholera vaccine herd protection into economic cost-benefit and cost-effectiveness models. Procedia Vaccinol. 2010;2(2010):140-6. doi: 10.1016/j.provac.2010.07.006